ConductScience.org, home

Paper7979253

Control of RNA initiation and elongation at the HIV-1 promoter.

Jones KA and 1 other. Annu Rev Biochem, 1994. Cited by 565 papers, by iCite.

Cite this record

ConductScience Library. Control of RNA initiation and elongation at the HIV-1 promoter. Papers, record 7979253. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7979253

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Control of RNA initiation and elongation at the HIV-1 promoter.
PubMed
Journal
Annu Rev Biochem
PubMed
Year
1994
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
565
iCite
Relative citation ratio, by iCite
10.5
iCite
Revised in PubMed
2024-01-04
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jones KAK A
2Peterlin BMB M

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gene Expression Regulation, ViralMajor topic
HIV-1Major topic
Promoter Regions, GeneticMajor topic
Transcription, GeneticMajor topic
Amino Acid Sequence
Base Sequence
Molecular Sequence Data
RNA, Viral
Transcriptional Activation

Source PubMed

Download CSV of topics

Cited by216

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 565 citations.

PMIDTitleJournalYearIn PapersSource
42947143Virus-informed targeting of HIV reservoirs: Rev-dependent HIV Immunotherapy (RHIT).Retrovirology2026https://conductscience.org/library/papers/42947143PubMed
40497153HIV-1 latency: From acquaintance to confidant.J Virus Erad2025https://conductscience.org/library/papers/40497153PubMed
40360701Intragenic viral silencer element regulates HTLV-1 latency via RUNX complex recruitment.Nat Microbiol2025https://conductscience.org/library/papers/40360701PubMed
39599797Involvement of Human Cellular Proteins and Structures in Realization of the HIV Life Cycle: A Comprehensive Review, 2024.Viruses2024https://conductscience.org/library/papers/39599797PubMed
39203549Adeno-Associated Virus (AAV)-Delivered Exosomal TAT and BiTE Molecule CD4-αCD3 Facilitate the Elimination of CD4 T Cells Harboring Latent HIV-1.Microorganisms2024https://conductscience.org/library/papers/39203549PubMed
38411060HIV-1 RNA genome packaging: it's G-rated.mBio2024https://conductscience.org/library/papers/38411060PubMed
38257808HIV Expression in Infected T Cell Clones.Viruses2024https://conductscience.org/library/papers/38257808PubMed
38145947RNet: a network strategy to predict RNA binding preferences.Brief Bioinform2023https://conductscience.org/library/papers/38145947PubMed
37766271A CRISPR Screen of HIV Dependency Factors Reveals That CCNT1 Is Non-Essential in T Cells but Required for HIV-1 Reactivation from Latency.Viruses2023https://conductscience.org/library/papers/37766271PubMed
36434173Effects of polybrene and retronectin as transduction enhancers on the development and phenotypic characteristics of VHH-based CD19-redirected CAR T cells: a comparative investigation.Clin Exp Med2023https://conductscience.org/library/papers/36434173PubMed
35632645HIV RGB: Automated Single-Cell Analysis of HIV-1 Rev-Dependent RNA Nuclear Export and Translation Using Image Processing in KNIME.Viruses2022https://conductscience.org/library/papers/35632645PubMed
34762866The TAR binding dynamics and its implication in Tat degradation mechanism.Biophys J2021https://conductscience.org/library/papers/34762866PubMed
33343516From Entry to Egress: Strategic Exploitation of the Cellular Processes by HIV-1.Front Microbiol2020https://conductscience.org/library/papers/33343516PubMed
32824587Y44A Mutation in the Acidic Domain of HIV-2 Tat Impairs Viral Reverse Transcription and LTR-Transactivation.Int J Mol Sci2020https://conductscience.org/library/papers/32824587PubMed
32573496Filgotinib suppresses HIV-1-driven gene transcription by inhibiting HIV-1 splicing and T cell activation.J Clin Invest2020https://conductscience.org/library/papers/32573496PubMed
32346097Nucleic acid recognition and antiviral activity of 1,4-substituted terphenyl compounds mimicking all faces of the HIV-1 Rev protein positively-charged α-helix.Sci Rep2020https://conductscience.org/library/papers/32346097PubMed
31239053Design of RNA-targeting macrocyclic peptides.Methods Enzymol2019https://conductscience.org/library/papers/31239053PubMed
30808702HIV-1 Escape from Small-Molecule Antagonism of Vif.mBio2019https://conductscience.org/library/papers/30808702PubMed
30670656Apobec3A maintains HIV-1 latency through recruitment of epigenetic silencing machinery to the long terminal repeat.Proc Natl Acad Sci U S A2019https://conductscience.org/library/papers/30670656PubMed
30524389Proteasomal Degradation Machinery: Favorite Target of HIV-1 Proteins.Front Microbiol2018https://conductscience.org/library/papers/30524389PubMed

See all 216 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7979253

GET https://conductscience.org/api/papers/v1/7979253/cited_by?page=2